1700011L22Rik Activators
1700011L22Rik Activators are a curated set of chemical compounds that enhance the functional activity of the 1700011L22Rik protein, each selected based on their mode of action within specific cellular signaling pathways. Forskolin, by increasing intracellular cAMP, indirectly enhances the activity of 1700011L22Rik through PKA activation, which can phosphorylate proteins including potentially 1700011L22Rik, assuming it is a substrate for PKA. Dibutyryl-cAMP, a more stable cAMP analog, reinforces this pathway by persistently activating PKA, thereby potentially maintaining 1700011L22Rik in a phosphorylated and active state. Ionomycin and A23187, both of which increase intracellular calcium levels, activate calcium-dependent kinases that may phosphorylate 1700011L22Rik, assuming it is part of calcium-sensitive signaling networks. Sildenafil and Zaprinast, inhibitors of phosphodiesterase 5, raise cGMP levels, which could activate PKG and subsequently enhance the activity of 1700011L22Rik if it interacts with cGMP-dependent signaling.
The influence of kinase signaling on 1700011L22Rik is further modulated by a range of kinase inhibitors. LY294002, a PI3K inhibitor, potentially activates alternative pathways that compensate for reduced AKT signaling, possibly upregulating 1700011L22Rik activity. PD98059 and SB203580, which inhibit MEK1/2 and p38 MAPK respectively, might shift the balance of cellular signaling to favor pathways that activate 1700011L22Rik. Epigallocatechin gallate, by inhibiting various protein kinases, could also remove inhibitory controls on 1700011L22Rik, enhancing its function. Okadaic acid, by preventing dephosphorylation through PP1 and PP2A inhibition, could maintain 1700011L22Rik in an active state if it is regulated by phosphorylation. Lastly, Anisomycin, a JNK activator, may augment the activity of 1700011L22Rik by promoting stress-activated signaling pathways. Collectively, these activators work through intricate cellular mechanisms to enhance the functional state of 1700011L22Rik without affecting its expression levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cell-permeable cAMP analog, directly activates PKA. The activation of PKA leads to the phosphorylation of target proteins, potentially including 1700011L22Rik, resulting in its enhanced functional activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is an ionophore that increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases could phosphorylate 1700011L22Rik, thereby increasing its activity if it is sensitive to calcium-mediated signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor, leading to decreased AKT signaling. This shift may result in the activation of compensatory pathways that upregulate the activity of 1700011L22Rik if it is part of the PI3K-AKT signaling axis. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK1/2, which may reduce ERK signaling and potentially activate alternative pathways that could enhance the activity of 1700011L22Rik if it is modulated by MAPK signaling. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a polyphenol that inhibits various protein kinases. By inhibiting negative regulators, EGCG could enhance the activity of 1700011L22Rik if it is regulated by such kinases. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which may redirect signaling to pathways that activate 1700011L22Rik, enhancing its activity if it is involved in cellular stress responses modulated by p38. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium concentration, activating calcium-dependent signaling pathways that could lead to the enhanced activity of 1700011L22Rik if it is calcium-responsive. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels within the cell. This could enhance 1700011L22Rik activity if it is regulated by reversible phosphorylation. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits phosphodiesterases, particularly PDE5, increasing cGMP levels which may activate PKG. Activation of PKG could then enhance the activity of 1700011L22Rik if it is part of cGMP-mediated signaling. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a JNK activator that can also inhibit protein synthesis. By activating JNK, it could enhance the activity of 1700011L22Rik if it is involved in pathways modulated by JNK signaling. | ||||||